Patent intelligence · US
US 9132201
Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
Patent details — US 9132201
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 15, 2015
- Expiration
- Sep 10, 2035
- Claims
- 21
- CPC classes
- A61K, A61K47/54, A61K47/6903, A61P
Quick answer
US 9132201 (Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers) is held by UNIVERSITY OF TWENTE, INSTITUTE FOR BIOMEDICAL AND TECHNICAL MEDICINE (MIRA). Status: granted. Granted Sep 15, 2015. Expires Sep 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 21
- CPC classes
- A61K, A61K47/54, A61K47/6903, A61P, A61P19/00, A61P19/02
More from UNIVERSITY OF TWENTE, INSTITUTE FOR BIOMEDICAL AND TECHNICAL MEDICINE (MIRA)
Related pharmaceutical patents in our USPTO index.
-
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12414911
Topical compositions and methods of use
granted -
US 12412764
Substrate-accommodating container
granted -
US 12398154
Azaquinazoline pan-KRas inhibitors
granted -
US 12383503
Adagrasib solid pharmaceutical compositions
granted -
US 12377101
Combination therapies
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted
Frequently asked questions
What is US patent 9132201?
US 9132201 (Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers) is held by UNIVERSITY OF TWENTE, INSTITUTE FOR BIOMEDICAL AND TECHNICAL MEDICINE (MIRA). Status: granted. Granted Sep 15, 2015. Expires Sep 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9132201?
UNIVERSITY OF TWENTE, INSTITUTE FOR BIOMEDICAL AND TECHNICAL MEDICINE (MIRA) is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 308 pharmaceutical patents for this assignee.
When does US 9132201 expire?
Our index shows an expiration date of Sep 10, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.